Acoustic Neuroma Clinical Trial
— PANQOLOfficial title:
Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised
This study has investigated the quality of life of patients with vestibular schwannoma using this specific scale prospectively, whether treated surgically or monitored.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 5, 2020 |
Est. primary completion date | December 5, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - be in possession of an acoustic neuroma (or vestibular schwannoma) confirmed in MRI, unilateral, unoperated - Age over 18 years - patient insured or beneficiary of a social security scheme - free, informed and express Exclusion Criteria: - History of surgery of the angle ponto-cerebellar or otologic - Neurofibromatosis type 2 - Cons-indication to MRI - psychiatric pathology - Pregnant or breastfeeding women |
Country | Name | City | State |
---|---|---|---|
France | University Hospital, Bordeaux | Bordeaux |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Bordeaux |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Score of PANQUOL Questionnaire | The PANQOL scale (Penn Acoustic Neuroma Quality-of-Life) is a specific questionnaire containing 26 items Interviewing 7 areas: hearing, balance, facial expression, anxiety, vitality, pain, and 'general health. The score is encrypted from 0 to 100, and the highest score is a reflection of the best possible quality of life. This score has been translated from French into English and validated according to the reverse translation rules by usual Oddon et al. | Month 1 | |
Primary | Score of PANQUOL Questionnaire | The PANQOL scale (Penn Acoustic Neuroma Quality-of-Life) is a specific questionnaire containing 26 items Interviewing 7 areas: hearing, balance, facial expression, anxiety, vitality, pain, and 'general health. The score is encrypted from 0 to 100, and the highest score is a reflection of the best possible quality of life. This score has been translated from French into English and validated according to the reverse translation rules by usual Oddon et al. | Month 3 | |
Primary | Score of PANQUOL Questionnaire | The PANQOL scale (Penn Acoustic Neuroma Quality-of-Life) is a specific questionnaire containing 26 items Interviewing 7 areas: hearing, balance, facial expression, anxiety, vitality, pain, and 'general health. The score is encrypted from 0 to 100, and the highest score is a reflection of the best possible quality of life. This score has been translated from French into English and validated according to the reverse translation rules by usual Oddon et al. | Month 6 | |
Primary | Score of PANQUOL Questionnaire | The PANQOL scale (Penn Acoustic Neuroma Quality-of-Life) is a specific questionnaire containing 26 items Interviewing 7 areas: hearing, balance, facial expression, anxiety, vitality, pain, and 'general health. The score is encrypted from 0 to 100, and the highest score is a reflection of the best possible quality of life. This score has been translated from French into English and validated according to the reverse translation rules by usual Oddon et al. | Month 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01199978 -
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
|
Phase 2 | |
Recruiting |
NCT06322342 -
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
|
Phase 2 | |
Completed |
NCT00863122 -
Concentration and Activity of Lapatinib in Vestibular Schwannomas
|
Early Phase 1 | |
Recruiting |
NCT03079999 -
Study of Aspirin in Patients With Vestibular Schwannoma
|
Phase 2 | |
Completed |
NCT03210285 -
WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
|
||
Completed |
NCT04241679 -
Auditory Nerve Test System During Vestibular Schwannoma Resection
|
N/A | |
Recruiting |
NCT03393689 -
RGD PET/MRI in Sporadic Vestibular Schwannoma
|
Phase 2 | |
Not yet recruiting |
NCT06112509 -
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
|
N/A | |
Withdrawn |
NCT03057678 -
Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery
|
N/A | |
Terminated |
NCT02282917 -
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
|
Early Phase 1 | |
Withdrawn |
NCT03261726 -
Maintaining Cochlear Patency After VIIIth Nerve Surgery
|
N/A |